{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:26:24Z","timestamp":1785803184962,"version":"3.56.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T00:00:00Z","timestamp":1606694400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Replication-deficient chimpanzee adenovirus (ChAd) vectors represent an attractive vaccine platform and are thus employed as vaccine candidates against several infectious diseases. Since inducing effective immunity depends on the interplay between innate and adaptive immunity, a deeper understanding of innate immune responses elicited by intramuscularly injected ChAd vectors in tissues can advance the platform\u2019s development. Using different candidate vaccines based on the Group C ChAd type 155 (ChAd155) vector, we characterized early immune responses in injected muscles and draining lymph nodes (dLNs) from mice, and complemented these analyses by evaluating cytokine responses and gene expression patterns in peripheral blood from ChAd155-injected macaques. In mice, vector DNA levels gradually decreased post-immunization, but local transgene mRNA expression exhibited two transient peaks [at 6\u00a0h and Day (D)5], which were most obvious in dLNs. This dynamic pattern was mirrored by the innate responses in tissues, which developed as early as 1\u20133 h (cytokines\/chemokines) or D1 (immune cells) post-vaccination. They were characterized by a CCL2- and CXCL9\/10-dominated chemokine profile, peaking at 6\u00a0h (with CXCL10\/CCL2 signals also detectable in serum) and D7, and clear immune-cell infiltration peaks at D1\/D2 and D6\/D7. Experiments with a green fluorescent protein-expressing ChAd155 vector revealed infiltrating hematopoietic cell subsets at the injection site. Cell infiltrates comprised mostly monocytes in muscles, and NK cells, T cells, dendritic cells, monocytes, and B cells in dLNs. Similar bimodal dynamics were observed in whole-blood gene signatures in macaques: most of the 17 enriched immune\/innate signaling pathways were significantly upregulated at D1 and D7 and downregulated at D3, and clustering analysis revealed stronger similarities between D1 and D7 signatures versus the D3 signature. Serum cytokine responses (CXCL10, IL1Ra, and low-level IFN-\u03b1) in macaques were predominantly observed at D1. Altogether, the early immune responses exhibited bimodal kinetics with transient peaks at D1\/D2 and D6\/D7, mostly with an IFN-associated signature, and these features were remarkably consistent across most analyzed parameters in murine tissues and macaque blood. These compelling observations reveal a novel aspect of the dynamics of innate immunity induced by ChAd155-vectored vaccines, and contribute to ongoing research to better understand how adenovectors can promote vaccine-induced immunity.<\/jats:p>","DOI":"10.3389\/fimmu.2020.579872","type":"journal-article","created":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T06:32:41Z","timestamp":1606717961000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Innate Immune Responses to Chimpanzee Adenovirus Vector 155 Vaccination in Mice and Monkeys"],"prefix":"10.3389","volume":"11","author":[{"given":"Catherine","family":"Collignon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanesa","family":"Bol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Chalon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Surendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Capone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviane","family":"Bechtold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane T.","family":"Temmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.Coviro.2016.06.001","article-title":"Viral Vectors as Vaccine Carriers","volume":"21","author":"Ertl","year":"2016","journal-title":"Curr Opin Virol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/Ki.1996.269","article-title":"Progress in Human Gene Therapy","volume":"49","author":"Feuerbach","year":"1996","journal-title":"Kidney Int"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1419108","article-title":"Development of Novel Vaccine Vectors: Chimpanzee Adenoviral Vectors","volume":"14","author":"Guo","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1586\/Erv.13.15","article-title":"Development of Chimpanzee Adenoviruses as Vaccine Vectors: Challenges and Successes Emerging From Clinical Trials","volume":"12","author":"Capone","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1394842","article-title":"Chimpanzee Adenoviral Vectors as Vaccines - Challenges to Move the Technology Into the Fast Lane","volume":"16","author":"Vitelli","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1126\/Scitranslmed.3002925","article-title":"Vaccine Vectors Derived From a Large Collection of Simian Adenoviruses Induce Potent Cellular Immunity Across Multiple Species","volume":"4","author":"Colloca","year":"2012","journal-title":"Sci Transl Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/Cid\/Ciz653","article-title":"First-in-Human Randomized Study to Assess the Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus (RSV) Vaccine Based on Chimpanzee-Adenovirus-155 Viral Vector-Expressing RSV Fusion, Nucleocapsid, and Antitermination Viral Proteins in Healthy Adults","volume":"70","author":"Cicconi","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/J.Jinf.2019.02.003","article-title":"Novel Genetically-Modified Chimpanzee Adenovirus and MVA-Vectored Respiratory Syncytial Virus Vaccine Safely Boosts Humoral and Cellular Immunity in Healthy Older Adults","volume":"78","author":"Green","year":"2019","journal-title":"J Infect"},{"key":"B9","doi-asserted-by":"publisher","first-page":"261ra153","DOI":"10.1126\/Scitranslmed.3009185","article-title":"A Human Vaccine Strategy Based on Chimpanzee Adenoviral and MVA Vectors That Primes, Boosts, and Sustains Functional HCV-Specific T Cell Memory","volume":"6","author":"Swadling","year":"2014","journal-title":"Sci Transl Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30016-5","article-title":"Safety, Reactogenicity, and Immunogenicity of a Chimpanzee Adenovirus Vectored Ebola Vaccine in Adults in Africa: a Randomised, Observer-Blind, Placebo-Controlled, Phase 2 Trial","volume":"20","author":"Tapia","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30019-0","article-title":"Safety, Reactogenicity, and Immunogenicity of a Chimpanzee Adenovirus Vectored Ebola Vaccine in Children in Africa: a Randomised, Observer-Blind, Placebo-Controlled, Phase 2 Trial","volume":"20","author":"Tapia","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"B12","volume-title":"Inventor. Novel Adenovirus. International Patent Publication Number WO2017017049A1","author":"Colloca","year":"2017"},{"key":"B13","unstructured":"Chad155-RSV Part 1 (Council Decision 2002\/813\/EC) Summary Notification Information Format for the Release of Genetically Modified Organisms Other Than Higher Plants in Accordance With Article 11 of Directive 2001\/18\/EC. Eudract Number: 2018-000431-272018"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1128\/Jvi.76.1.127-135.2002","article-title":"Adenovirus Hexon Protein Is a Potent Adjuvant for Activation of a Cellular Immune Response","volume":"76","author":"Molinier-Frenkel","year":"2002","journal-title":"J Virol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01597-10","article-title":"Multiple Innate Immune Pathways Contribute to the Immunogenicity of Recombinant Adenovirus Vaccine Vectors","volume":"85","author":"Rhee","year":"2011","journal-title":"J Virol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/J.Vaccine.2013.11.055","article-title":"Type I Interferon-Dependent Activation of NK Cells by Rad28 or Rad35, But Not Rad5, Leads to Loss of Vector-Insert Expression","volume":"32","author":"Johnson","year":"2014","journal-title":"Vaccine"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1172\/JCI78280","article-title":"Antigen Expression Determines Adenoviral Vaccine Potency Independent of IFN and STING Signaling","volume":"125","author":"Quinn","year":"2015","journal-title":"J Clin Invest"},{"key":"B18","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/Sj.Mt.6300024","article-title":"Type I Interferon Inhibits Antibody Responses Induced by a Chimpanzee Adenovirus Vector","volume":"15","author":"Hensley","year":"2007","journal-title":"Mol Ther"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/J.Vaccine.2019.01.045","article-title":"Viral Vector and Route of Administration Determine the ILC and DC Profiles Responsible for Downstream Vaccine-Specific Immune Outcomes","volume":"37","author":"Roy","year":"2019","journal-title":"Vaccine"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00740-12","article-title":"Vaccination With Adenovirus Serotypes 35, 26, and 48 Elicits Higher Levels of Innate Cytokine Responses Than Adenovirus Serotype 5 in Rhesus Monkeys","volume":"86","author":"Teigler","year":"2012","journal-title":"J Virol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1089\/Hum.2014.001","article-title":"Innate Immunity to Adenovirus","volume":"25","author":"Hendrickx","year":"2014","journal-title":"Hum Gene Ther"},{"key":"B22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3109\/08830185.2013.823420","article-title":"Adenoviruses Types, Cell Receptors and Local Innate Cytokines in Adenovirus Infection","volume":"33","author":"Chen","year":"2014","journal-title":"Int Rev Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4049\/Jimmunol.1000338","article-title":"CD8+ T Cell Responses Following Replication-Defective Adenovirus Serotype 5 Immunization Are Dependent on CD11c+ Dendritic Cells But Show Redundancy in Their Requirement of TLR and Nucleotide-Binding Oligomerization Domain-Like Receptor Signaling","volume":"185","author":"Lindsay","year":"2010","journal-title":"J Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.4049\/Jimmunol.1202861","article-title":"Comparative Analysis of the Magnitude, Quality, Phenotype, and Protective Capacity of Simian Immunodeficiency Virus Gag-Specific CD8+ T Cells Following Human-, Simian-, and Chimpanzee-Derived Recombinant Adenoviral Vector Immunization","volume":"190","author":"Quinn","year":"2013","journal-title":"J Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"E0008459","DOI":"10.1371\/Journal.Pntd.0008459","article-title":"A Next Generation Vaccine Against Human Rabies Based on a Single Dose of a Chimpanzee Adenovirus Vector Serotype C","volume":"14","author":"Napolitano","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/Jps.20157","article-title":"Development of Stable Liquid Formulations for Adenovirus-Based Vaccines","volume":"93","author":"Evans","year":"2004","journal-title":"J Pharm Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4049\/Jimmunol.0901474","article-title":"AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity","volume":"183","author":"Didierlaurent","year":"2009","journal-title":"J Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.4049\/Jimmunol.1400948","article-title":"Enhancement of Adaptive Immunity by the Human Vaccine Adjuvant AS01 Depends on Activated Dendritic Cells","volume":"193","author":"Didierlaurent","year":"2014","journal-title":"J Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1186\/Gb-2002-3-7-Research0034","article-title":"Accurate Normalization of Real-Time Quantitative RT-PCR Data by Geometric Averaging of Multiple Internal Control Genes","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"E151","DOI":"10.1093\/Nar\/Gkw677","article-title":"Nanostringdiff: a Novel Statistical Method for Differential Expression Analysis Based on Nanostring Ncounter Data","volume":"44","author":"Wang","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/1471-2105-6-225","article-title":"Pathway Level Analysis of Gene Expression Using Singular Value Decomposition","volume":"6","author":"Tomfohr","year":"2005","journal-title":"BMC Bioinf"},{"key":"B32","doi-asserted-by":"publisher","first-page":"E1002352","DOI":"10.1371\/Journal.Ppat.1002352","article-title":"Type 1 Interferons and Antiviral CD8 T-Cell Responses","volume":"8","author":"Welsh","year":"2012","journal-title":"PLoS Pathog"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/Imr.12742","article-title":"Regulators of T-Cell Fate: Integration of Cell Migration, Differentiation and Function","volume":"289","author":"Groom","year":"2019","journal-title":"Immunol Rev"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.3.1277","article-title":"Chemotactic Responsiveness Toward Ligands for CXCR3 and CXCR4 Is Regulated on Plasma Blasts During the Time Course of a Memory Immune Response","volume":"169","author":"Hauser","year":"2002","journal-title":"J Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.4049\/Jimmunol.1102744","article-title":"CD64 Expression Distinguishes Monocyte-Derived and Conventional Dendritic Cells and Reveals Their Distinct Role During Intramuscular Immunization","volume":"188","author":"Langlet","year":"2012","journal-title":"J Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/J.Vaccine.2010.12.090","article-title":"Vaccine Adjuvants Alum and MF59 Induce Rapid Recruitment of Neutrophils and Monocytes That Participate in Antigen Transport to Draining Lymph Nodes","volume":"29","author":"Calabro","year":"2011","journal-title":"Vaccine"},{"key":"B37","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/J.Jim.2015.06.011","article-title":"Dissociation of Skeletal Muscle for Flow Cytometric Characterization of Immune Cells in Macaques","volume":"425","author":"Liang","year":"2015","journal-title":"J Immunol Methods"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1006\/Mthe.2001.0318","article-title":"Tnfa and Ifng Induced by Innate Anti-Adenoviral Immune Responses Inhibit Adenovirus-Mediated Transgene Expression","volume":"3","author":"Sung","year":"2001","journal-title":"Mol Ther"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/Sj.Gt.3302675","article-title":"Chimpanzee-Origin Adenovirus Vectors as Vaccine Carriers","volume":"13","author":"Tatsis","year":"2006","journal-title":"Gene Ther"},{"key":"B40","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/J.Immuni.2015.03.001","article-title":"Infected Cells Call Their Killers to the Scene of the Crime","volume":"42","author":"Beura","year":"2015","journal-title":"Immunity"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/J.Immuni.2015.02.009","article-title":"CXCR3 Chemokine Receptor Enables Local CD8+ T Cell Migration for the Destruction of Virus-Infected Cells","volume":"42","author":"Hickman","year":"2015","journal-title":"Immunity"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/J.Autrev.2017.12.005","article-title":"Skeletal Muscle Cells Actively Shape (Auto)Immune Responses","volume":"17","author":"Afzali","year":"2018","journal-title":"Autoimmun Rev"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/J.Ejcb.2011.09.011","article-title":"Inflammatory Response in Human Skeletal Muscle Cells: CXCL10 as a Potential Therapeutic Target","volume":"91","author":"Crescioli","year":"2012","journal-title":"Eur J Cell Biol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"16756","DOI":"10.1038\/Srep16756","article-title":"Differential Immunogenicity Between Hadv-5 and Chimpanzee Adenovirus Vector Chadox1 Is Independent of Fiber and Penton RGD Loop Sequences in Mice","volume":"21","author":"Dicks","year":"2015","journal-title":"Sci Rep"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31208-3","article-title":"Safety, Tolerability, and Immunogenicity of a Recombinant Adenovirus Type-5 Vectored COVID-19 Vaccine: a Dose-Escalation, Open-Label, Non-Randomised, First-in-Human Trial","volume":"395","author":"Zhu","year":"2020","journal-title":"Lancet"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2608-y","article-title":"ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques","volume":"586","author":"van Doremalen","year":"2020","journal-title":"Nature"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/S41541-020-00221-3","article-title":"Evaluation of the Immunogenicity of Prime-Boost Vaccination With the Replication-Deficient Viral Vectored COVID-19 Vaccine Candidate Chadox1 Ncov-19","author":"Graham","year":"2020","journal-title":"NPJ Vaccines"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31604-4","article-title":"Safety and Immunogenicity of the Chadox1 Ncov-19 Vaccine Against SARS-Cov-2: a Preliminary Report of a Phase 1\/2, Single-Blind, Randomised Controlled Trial","volume":"396","author":"Folegatti","year":"2020","journal-title":"Lancet"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.579872\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T06:32:54Z","timestamp":1606717974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.579872\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,30]]},"references-count":48,"alternative-id":["10.3389\/fimmu.2020.579872"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.579872","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,30]]},"article-number":"579872"}}